These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 39221762)

  • 1. Comprehensive scRNA-seq analysis to identify new markers of M2 macrophages for predicting the prognosis of prostate cancer.
    Ou Y; Xia C; Ye C; Liu M; Jiang H; Zhu Y; Yang D
    Ann Med; 2024 Dec; 56(1):2398195. PubMed ID: 39221762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of macrophage-related genes in prostate cancer by integrated analysis of single-cell and bulk RNA sequencing.
    Zhang J; Li Z; Chen Z; Shi W; Xu Y; Huang Z; Lin Z; Dou R; Lin S; Jiang X; Li M; Jiang S
    Aging (Albany NY); 2024 Apr; 16(8):6809-6838. PubMed ID: 38663915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the immune landscape and drug prediction of an M2 tumor-associated macrophage-related gene signature in EGFR-negative lung adenocarcinoma.
    Huang Y; Zhang Y; Duan X; Hou R; Wang Q; Shi J
    Thorac Cancer; 2024 Jul; 15(21):1626-1637. PubMed ID: 38886907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Based on scRNA-seq and bulk RNA-seq to establish tumor immune microenvironment-associated signature of skin melanoma and predict immunotherapy response.
    Li S; Zhao J; Wang G; Yao Q; Leng Z; Liu Q; Jiang J; Wang W
    Arch Dermatol Res; 2024 May; 316(6):262. PubMed ID: 38795156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
    J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis of tumor-associated macrophages and M2 macrophages in CRC: unraveling molecular heterogeneity and developing a novel risk signature.
    Shi L; Mao H; Ma J
    BMC Med Genomics; 2024 May; 17(1):145. PubMed ID: 38802881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma.
    Qu X; Zhao X; Lin K; Wang N; Li X; Li S; Zhang L; Shi Y
    Front Immunol; 2022; 13():994019. PubMed ID: 36177006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated Analysis Construct a Tumor-Associated Macrophage Novel Signature with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Gastric Cancer Patients.
    Xin H; Chen Y; Niu H; Li X; Gai X; Cui G
    Dig Dis Sci; 2024 Jun; 69(6):2055-2073. PubMed ID: 38573378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revealing a cancer-associated fibroblast-based risk signature for pancreatic adenocarcinoma through single-cell and bulk RNA-seq analysis.
    Ma J; Chen Z; Hou L
    Aging (Albany NY); 2024 Sep; 16(18):12525-12542. PubMed ID: 39332020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key platelet genes play important roles in predicting the prognosis of sepsis.
    Shen L; Tao C; Zhu K; Cai L; Yang S; Jin J; Ren Y; Xiao Y; Zhang Y; Lai D; Tou J
    Sci Rep; 2024 Oct; 14(1):23530. PubMed ID: 39384856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Molecular Analyses of an M2-Like Tumor-Associated Macrophage for Predicting the Prognosis and Immunotherapy in Breast Cancer.
    Chang K; Yue Q; Jin L; Fan P; Liu Y; Cao F; Zhang Y
    J Immunother; 2024 Jul-Aug 01; 47(6):205-215. PubMed ID: 38686904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Transcriptomic Signatures of Pancreatic Ductal Adenocarcinoma-Derived Exosomes That Promote Macrophage M2 Polarization and Predict Prognosis: S100A9 Reveals Tumor Progression.
    Tan S; Tang H; Zhang Z; Wang Y; Li H; Shi W; Ye H; Xie P; Zhou J
    Clin Med Insights Oncol; 2024; 18():11795549241239042. PubMed ID: 38510315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating single-cell RNA-seq to identify fibroblast-based molecular subtypes for predicting prognosis and therapeutic response in bladder cancer.
    Wang J; Tan Z; Huang Y; Li C; Zhan P; Wang H; Li H
    Aging (Albany NY); 2024 Jul; 16(14):11385-11408. PubMed ID: 39033778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the Prognosis and Tumor Microenvironment of Cellular Senescence-related Genes through scRNA-seq and Bulk RNA-seq Analysis in GC.
    Guo G; Zhou Z; Chen S; Cheng J; Wang Y; Lan T; Ye Y
    Recent Pat Anticancer Drug Discov; 2024; 19(4):530-542. PubMed ID: 37807645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-seq and bulk RNA-seq data analysis of cancer-related fibroblasts (CAF) in LUAD to construct a CAF-based risk signature.
    Si Y; Zhao Z; Meng X; Zhao K
    Sci Rep; 2024 Oct; 14(1):23243. PubMed ID: 39369095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
    Wang Z; Tu L; Chen M; Tong S
    BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of recurrence marker associated with immune infiltration in prostate cancer with radical resection and build prognostic nomogram.
    Rui X; Shao S; Wang L; Leng J
    BMC Cancer; 2019 Dec; 19(1):1179. PubMed ID: 31795990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer.
    Chen Y; Chen Z; Mo J; Pang M; Chen Z; Feng F; Xie P; Yang B
    Technol Cancer Res Treat; 2021; 20():1533033821990064. PubMed ID: 33596783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.